Skip to main content
Caplight Logo









Genomenon Inc.

Genomenon Inc.

Private
Ann Arbor, MichiganHealthcare & Life Scienceshttps://www.genomenon.com/

Last Round

Early Funding

Jul 30, 2026

Total Funding Raised

$33.1M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Genomenon Inc. is an AI-driven genomics company that provides software, data, and services for genomic information analysis to support clinical and pharmaceutical organizations.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Healthcare Analytics, Medical AI, Drug Discovery, Biotechnology

Business Model

B2B

Customer Profile

Subscription SaaS, Data as a Service, Services & Consulting, Freemium, Government Contracts

AI Layer

Application

Keywords

variant interpretationgenomic search engineAI genomicsevidence curationgene variant databasecancer genomicsrare disease diagnosisvariant classificationprecision medicinevariant curation servicesdrug discoverygenomic intelligence platformgenomic data APIgenomic literature mininggenomic language processing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Genomenon Inc. Comparables

Compare Genomenon Inc. with similar companies based on industry and business-model similarity.

Genomenon Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Saphetor
81%
SeqOne
79%
Geneyx
78%

Genomenon Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingJul 30, 2026
Series BMar 10, 2022
GrantFeb 15, 2022
Series AMar 16, 2021
SeedJan 8, 2019
Grant
Apr 25, 2017

Key People

Founding team and executive leadership

Mark J. Kiel

Chief Science Officer Founder

Founding Team

Mike Klein

Chief Executive Officer

Executive Team

Brian Groark

Chief Financial Officer

Executive Team

Samuel Globus

Chief Operating Officer

Executive Team

Genomenon Inc. Investors

Notable investors and investment history

Genomenon Inc. investors
InvestorRounds
Invest DetroitSeed
NIH RADxGrant
Monroe-Brown FoundationSeed
University of MichiganSeries B
BeringeaSeries B
Ann Arbor SPARKSeries A, Series B, Seed
Michigan Investment in New Technology StartupsSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 30, 2026

    Raised $6M in seed funding.

  • Jan 22, 2026

    Monthly visitors increased 45% MoM, reaching 32.8K.

Genomenon Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Genomenon Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Genomenon Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersAnn Arbor, Michigan
Employee Range136
Year Founded2014
Last FundingJul 30, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?